KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test
Welcome to DNA Labs UAE, your trusted genetic lab in UAE. In this blog, we will discuss the KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test, including its cost, symptoms, diagnosis, and other important details.
Test Name: KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for KAT6A Gene Mental retardation, autosomal dominant type 32 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KAT6A Gene Mental retardation, autosomal dominant type 32.
Test Details
The KAT6A gene is associated with a condition called mental retardation, autosomal dominant type 32 (MRD32). This condition is characterized by intellectual disability, developmental delay, and other neurological abnormalities.
NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MRD32, NGS genetic testing can be used to identify any mutations or variations in the KAT6A gene that may be causing the condition. By identifying the specific genetic mutation or variation in the KAT6A gene, NGS genetic testing can provide a definitive diagnosis for individuals suspected of having MRD32. This can help guide medical management, provide information on recurrence risks, and offer genetic counseling to affected individuals and their families.
Thank you for reading our blog on the KAT6A Gene Mental Retardation Autosomal Dominant Type 32 Genetic Test. If you have any further questions or would like to schedule a test, please contact our Genetics Test Department or consult with a Neurologist.
Test Name | KAT6A Gene Mental retardation autosomal dominant type 32 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KAT6A Gene Mental retardation, autosomal dominant type 32 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KAT6A Gene Mental retardation, autosomal dominant type 32 |
Test Details |
The KAT6A gene is associated with a condition called mental retardation, autosomal dominant type 32 (MRD32). This condition is characterized by intellectual disability, developmental delay, and other neurological abnormalities. NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MRD32, NGS genetic testing can be used to identify any mutations or variations in the KAT6A gene that may be causing the condition. By identifying the specific genetic mutation or variation in the KAT6A gene, NGS genetic testing can provide a definitive diagnosis for individuals suspected of having MRD32. This can help guide medical management, provide information on recurrence risks, and offer genetic counseling to affected individuals and their families. |